Randomised Trial of Two Intravenous Schedules of the Liposomal Topoisomerase I Inhibitor, OSI-211, in Women With Relapsed Epithelial Ovarian Cancer. A Trial of the National Cancer Institute of Canada Clinical Trials Group

GG Dark; AH Calvert; R Grimshaw; C Poole; K Swenerton; S Kaye; R Coleman; G Jayson; T Le; S Ellard; M Trudeau1; P Vasey; M Hamilton; T Cameron; E Barrett; W Walsh; L McIntosh; E Eisenhauer

Randomised Trial of Two Intravenous Schedules of the Liposomal Topoisomerase I Inhibitor, OSI-211, in Women With Relapsed Epithelial Ovarian Cancer. A Trial of the National Cancer Institute of Canada Clinical Trials Group

GG Dark
, AH Calvert
, R Grimshaw
, C Poole
, K Swenerton
, S Kaye
, R Coleman
, G Jayson
, T Le
, S Ellard
, M Trudeau1
, P Vasey
, M Hamilton
, T Cameron
, E Barrett
, W Walsh
, L McIntosh
, E Eisenhauer

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1859-1866
Journal	J Clin Oncol
Publication status	Published - 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Dark, GG., Calvert, AH., Grimshaw, R., Poole, C., Swenerton, K., Kaye, S., Coleman, R., Jayson, G., Le, T., Ellard, S., Trudeau1, M., Vasey, P., Hamilton, M., Cameron, T., Barrett, E., Walsh, W., McIntosh, L., & Eisenhauer, E. (2005). Randomised Trial of Two Intravenous Schedules of the Liposomal Topoisomerase I Inhibitor, OSI-211, in Women With Relapsed Epithelial Ovarian Cancer. A Trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol, 1859-1866.

@article{48d23b5fbcbc4e7cbcd2565b9d150ad7,

title = "Randomised Trial of Two Intravenous Schedules of the Liposomal Topoisomerase I Inhibitor, OSI-211, in Women With Relapsed Epithelial Ovarian Cancer. A Trial of the National Cancer Institute of Canada Clinical Trials Group",

author = "GG Dark and AH Calvert and R Grimshaw and C Poole and K Swenerton and S Kaye and R Coleman and G Jayson and T Le and S Ellard and M Trudeau1 and P Vasey and M Hamilton and T Cameron and E Barrett and W Walsh and L McIntosh and E Eisenhauer",

year = "2005",

language = "English",

pages = "1859--1866",

journal = "J Clin Oncol",

issn = "1527-7755",

publisher = "Lippincott Williams \& Wilkins",

}

Dark, GG, Calvert, AH, Grimshaw, R, Poole, C, Swenerton, K, Kaye, S, Coleman, R, Jayson, G, Le, T, Ellard, S, Trudeau1, M, Vasey, P, Hamilton, M, Cameron, T, Barrett, E, Walsh, W, McIntosh, L & Eisenhauer, E 2005, 'Randomised Trial of Two Intravenous Schedules of the Liposomal Topoisomerase I Inhibitor, OSI-211, in Women With Relapsed Epithelial Ovarian Cancer. A Trial of the National Cancer Institute of Canada Clinical Trials Group', J Clin Oncol, pp. 1859-1866.

Randomised Trial of Two Intravenous Schedules of the Liposomal Topoisomerase I Inhibitor, OSI-211, in Women With Relapsed Epithelial Ovarian Cancer. A Trial of the National Cancer Institute of Canada Clinical Trials Group. / Dark, GG; Calvert, AH; Grimshaw, R et al.
In: J Clin Oncol, 2005, p. 1859-1866.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Randomised Trial of Two Intravenous Schedules of the Liposomal Topoisomerase I Inhibitor, OSI-211, in Women With Relapsed Epithelial Ovarian Cancer. A Trial of the National Cancer Institute of Canada Clinical Trials Group

AU - Dark, GG

AU - Calvert, AH

AU - Grimshaw, R

AU - Poole, C

AU - Swenerton, K

AU - Kaye, S

AU - Coleman, R

AU - Jayson, G

AU - Le, T

AU - Ellard, S

AU - Trudeau1, M

AU - Vasey, P

AU - Hamilton, M

AU - Cameron, T

AU - Barrett, E

AU - Walsh, W

AU - McIntosh, L

AU - Eisenhauer, E

PY - 2005

Y1 - 2005

M3 - Article

SN - 1527-7755

SP - 1859

EP - 1866

JO - J Clin Oncol

JF - J Clin Oncol

ER -